Ono Pharmaceutical Co. Ltd (OPHLF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2020 | 03-2019 | 03-2018 | 03-2017 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 733,203 | 586,269 | 603,037 | 665,536 | 297,069 |
| Depreciation Amortization | 130,769 | 95,589 | 86,912 | 69,829 | 58,342 |
| Accounts receivable | -7,296 | 11,259 | -40,873 | -99,960 | -179,453 |
| Accounts payable and accrued liabilities | 18,326 | 8,982 | 2,827 | 44,463 | 83,145 |
| Other Working Capital | 45,282 | 66,537 | -39,744 | -32,817 | -135,397 |
| Other Operating Activity | -238,041 | -167,670 | -463,794 | 17,680 | -9,042 |
| Operating Cash Flow | $682,244 | $600,966 | $148,365 | $664,731 | $114,664 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 237,360 | 97,200 | N/A | N/A | N/A |
| PPE Investments | -64,869 | -200,628 | -103,363 | -129,738 | -54,327 |
| Purchase Of Investment | N/A | -7,857 | -566 | -28,933 | -7,707 |
| Sale Of Investment | 289,239 | 244,107 | 201,083 | 257,880 | 247,257 |
| Purchase Sale Intangibles | -137,724 | -65,691 | -134,136 | -82,805 | -63,043 |
| Other Investing Activity | -555,882 | -580,689 | -419,688 | -259,825 | -68,820 |
| Investing Cash Flow | $-94,153 | $-447,867 | $-322,534 | $-160,616 | $116,403 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -3,249 | -3,932 | -3,558 | -3,266 |
| Dividend Paid | -209,558 | -196,497 | -220,919 | -179,637 | -170,194 |
| Other Financing Activity | -293,876 | -765 | -365,231 | -301 | -337 |
| Financing Cash Flow | $-503,433 | $-200,511 | $-590,082 | $-183,496 | $-173,797 |
| Exchange Rate Effect | -1,647 | -216 | -379 | -630 | -1,356 |
| Beginning Cash Position | 551,825 | 587,457 | 1,380,410 | 986,471 | 930,557 |
| End Cash Position | 634,846 | 539,829 | 615,781 | 1,306,460 | 986,471 |
| Net Cash Flow | $83,021 | $-47,628 | $-764,629 | $319,989 | $55,914 |
| Free Cash Flow | |||||
| Operating Cash Flow | 682,244 | 600,966 | 148,365 | 664,731 | 114,664 |
| Capital Expenditure | -68,770 | -200,727 | -147,358 | -132,187 | -62,687 |
| Free Cash Flow | 613,474 | 400,239 | 1,007 | 532,544 | 51,977 |